Clinical Trials Browser

Head and Neck Neoplasms × IPI-926 × Clear all

NCT01255800 2014-01-31

Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer

Phase 1 Completed

Head and Neck Neoplasms